Cerni C H, Micksche M
Acta Neuropathol Suppl. 1975;Suppl 6:65-8. doi: 10.1007/978-3-662-08456-4_10.
The specific lymphocyte sensitization of patients with malignant diseases against a basic protein, isolated from human brain, was studied by the lymphocyte migration inhibition technique. A sensitization of lymphocytes of cancer patients against this encephalitogenic factor (EF) was first reported by FIELD and CASPARY in 1970. Their test system was the Macrophage-Electrophoretic-Mobility-Test (MEMT). In 17 out of 18 patients with malignant disease we found a specific inhibition or enhancement of the migration area of lymphocytes more than 15%.
采用淋巴细胞游走抑制技术，研究了恶性疾病患者对从人脑分离出的一种碱性蛋白的特异性淋巴细胞致敏作用。1970年，菲尔德和卡斯帕里首次报道癌症患者淋巴细胞对这种致脑炎因子（EF）致敏。他们的检测系统是巨噬细胞电泳迁移率试验（MEMT）。在18例恶性疾病患者中，我们发现17例患者淋巴细胞游走区域有超过15%的特异性抑制或增强。
